Authors’ Reply: To Letter to the Editor by Guo and Liu
Authors:
Angela Pecoraro
Angela PecoraroCancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy; and
Pierre I. KarakiewiczCancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada.
PecoraroA, RosielloG, LuzzagoS, et al.Small renal masses with tumor size 0 to 2 cm: a SEER-based study and validation of NCCN Guidelines. J Natl Compr Canc Netw2020;18:1340–1347.
PecoraroA, RosielloG, LuzzagoS, Small renal masses with tumor size 0 to 2 cm: a SEER-based study and validation of NCCN Guidelines. J Natl Compr Canc Netw 2020;18:1340–1347.10.6004/jnccn.2020.7577)| false
LipworthL, MorgansAK, EdwardsTL, Renal cell cancer histological subtype distribution differs by race and sex. BJU Int 2016;117:260–265.10.1111/bju.1295025307281)| false
RosielloG, PalumboC, KnipperS, et al.Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. Urol Oncol2020;38:537–544.
RosielloG, PalumboC, KnipperS, Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. Urol Oncol 2020;38:537–544.3212272910.1016/j.urolonc.2020.01.013)| false
RosielloG, PecoraroA, LuzzagoS, et al.Prognostic factors in patients with small renal masses: a comparison between <2 vs 2.1–4 cm renal cell carcinomas. Cancer Causes Control2020;32:119–126.
RosielloG, PecoraroA, LuzzagoS, Prognostic factors in patients with small renal masses: a comparison between <2 vs 2.1–4 cm renal cell carcinomas. Cancer Causes Control 2020;32:119–126.10.1007/s10552-020-01364-333169306)| false